Vivus and Auxilium (AUXL) announce FDA approval of STENDRA sNDA
6:01 AM ET 9/18/14 | Briefing.com Co and Auxilium (AUXL) announced that the FDA has approved a supplemental new drug application (sNDA) for STENDRA (avanafil). STENDRA is now the only FDA-approved erectile dysfunction medication indicated to be taken as early as ~ 15 minutes before sexual activity.
About 33 million short VVUS! And just 103.5 shares outstanding.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.